Combination of low dose rivaroxaban and aspirin in females and males with chronic coronary artery disease or peripheral artery disease

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Late Breaking Science in Cardiovascular Pharmacology Secondary Prevention ESC Premium Access ESC Congress 2019

ESC 365 is supported by

ESC 365 is supported by